Genome-wide DNA methylation profiling in human breast tissue by Illumina TruSeq methyl capture EPIC sequencing and infinium methylationEPIC beadchip microarray

References

• Greenberg MVC, Bourc’his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20(10):590–607.
   Google Scholar
• Liu Y, Li X, Aryee MJ, et al. GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. Am J Hum Genet. 2014;94(4):485–495. .
   Google Scholar
• Zeisel SH. Epigenetic mechanisms for nutrition determinants of later health outcomes. Am J Clin Nutr. 2009;89(5):1488S–1493S.
   Google Scholar
• Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008;105(44):17046–17049.
   Google Scholar
• Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005 Aug;6(8):597–610. doi: 10.1038/nrg1655.
   Google Scholar
• De Carvalho DD, You JS, Jones PA. DNA methylation and cellular reprogramming. Trends Cell Biol. 2010;20(10):609–617.
   Google Scholar
• Herceg Z, Vaissière T. Epigenetic mechanisms and cancer: an interface between the environment and the genome. Epigenetics. 2011;6(7):804–819.
   Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 2012;13(10):679–692.
   Google Scholar
• Teschendorff AE, Menon U, Gentry-Maharaj A, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010;20(4):440–446.
   Google Scholar
• Dick KJ, Nelson CP, Tsaprouni L, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014;383(9933):1990–1998.
   Google Scholar
• Rakyan VK, Down TA, Balding DJ, et al. Epigenome-wide association studies for common human diseases. Nat Rev Genet. 2011;12(8):529–541.
   Google Scholar
• Ziller MJ, Hansen KD, Meer A, et al. Coverage recommendations for methylation analysis by whole-genome bisulfite sequencing. Nat Methods. 2015;12(3):230.
   Google Scholar
• Moran S, Arribas C, Esteller M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 2016;8(3):389–399. In.: Epub 2015/ 12/18.PMID: 26673039. .
   Google Scholar
• Pidsley R, Zotenko E, Peters TJ, et al. Critical evaluation of the illumina MethylationEPIC beadchip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17(1):208.
   Google Scholar
• Illumina (2016) TruSeq methyl capture EPIC library prep kit.1-8
   Google Scholar
• Heiss JA, Brennan KJ, Baccarelli AA, et al. Battle of epigenetic proportions: comparing Illumina’s EPIC methylation microarrays and TruSeq targeted bisulfite sequencing. Epigenetics. 2020;15(1–2):174–182.
   Google Scholar
• Heiss JA, Just AC. Identifying mislabeled and contaminated DNA methylation microarray data: an extended quality control toolset with examples from GEO. Clin Epigenetics. 2018;10:73-81.
   Google Scholar
• Teh AL, Pan H, Lin X, et al. Comparison of methyl-capture sequencing vs. Infinium 450K methylation array for methylome analysis in clinical samples. Epigenetics. 2016;11(1):36–48.
   Google Scholar
• Lee E-J, Luo J, Wilson JM, et al. Analyzing the cancer methylome through targeted bisulfite sequencing. Cancer Lett. 2013;340(2):171–178.
   Google Scholar
• Gujar H, Liang JW, Wong NC, et al. Profiling DNA methylation differences between inbred mouse strains on the illumina human infinium methylationEPIC microarray. PLoS One. 2018;13(3):e0193496.
   Google Scholar
• Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363–1369.
   Google Scholar
• Dedeurwaerder S, Defrance M, Bizet M, et al. A comprehensive overview of infinium humanMethylation450 data processing. Brief Bioinform. 2014;15(6):929–941.
   Google Scholar
• Assenov Y, Müller F, Lutsik P, et al. Comprehensive analysis of DNA methylation data with RnBeads. Nat Methods. 2014;11(11):1138.
   Google Scholar
• Price EM, Cotton AM, Lam LL, et al. Additional annotation enhances potential for biologically-relevant analysis of the illumina infinium humanMethylation450 BeadChip array. Epigenetics Chromatin. 2013;6(1):4.
   Google Scholar
• Harris RA, Wang T, Coarfa C, et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol. 2010;28(10):1097.
   Google Scholar
• Carmona JJ, Accomando WP, Binder AM, et al. Empirical comparison of reduced representation bisulfite sequencing and Infinium BeadChip reproducibility and coverage of DNA methylation in humans. NPJ Genom Med. 2017;2(1):1–10.
   Google Scholar
• Jaksik R, Iwanaszko M, Rzeszowska-Wolny J, et al. Microarray experiments and factors which affect their reliability. Biol Direct. 2015;10(1):46.
   Google Scholar
• Skvortsov D, Abdueva D, Curtis C, et al. Explaining differences in saturation levels for affymetrix GeneChip® arrays. Nucleic Acids Res. 2007;35(12):4154–4163.
   Google Scholar
• Lee J-R, Ryu D-S, Park S-J, et al. Successful application of human-based methyl capture sequencing for methylome analysis in non-human primate models. BMC Genomics. 2018;19(1):267.
   Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. cell. 2000;100(1):57–70.
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. cell. 2011;144(5):646–674.
   Google Scholar
• Bock C, Tomazou EM, Brinkman AB, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol. 2010;28(10):1106–1114.
   Google Scholar
• Allum F, Shao X, Guenard F, et al. Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants. Nat Commun. 2015;6:7211.
   Google Scholar
• Graham K, Ge X, de Las Morenas A, et al. Gene expression profiles of estrogen receptor–positive and estrogen receptor–negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res. 2011;17(2):236–246.
   Google Scholar
• Yan PS, Venkataramu C, Ibrahim A, et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res. 2006;12(22):6626–6636. .
   Google Scholar
• Chandran UR, Dhir R, Ma C, et al. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer. 2005;5:45-55.
   Google Scholar
• Teschendorff AE, Gao Y, Jones A, et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. 2016;7:10478-10489.
   Google Scholar
• Krueger F (2015) Trim Galore!A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files.
   Google Scholar
• Church DM, Schneider VA, Graves T, et al. Modernizing reference genome assemblies. PLoS Biol. 2011;9(7):e1001091. .
   Google Scholar
• Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27(11):1571–1572.
   Google Scholar
• Tian Y, Morris TJ, Webster AP, et al. ChAMP: updated methylation analysis pipeline for illumina beadChips. Bioinformatics. 2017;33(24):3982–3984.
   Google Scholar
• Wu H, Xu T, Feng H, et al. Detection of differentially methylated regions from whole-genome bisulfite sequencing data without replicates. Nucleic Acids Res. 2015;43(21):e141–e141.
   Google Scholar
• Park Y, Wu H. Differential methylation analysis for BS-seq data under general experimental design. Bioinformatics. 2016;32(10):1446–1453.
   Google Scholar